This document discusses a new ocular biometer called Mirricon that aims to improve intraocular lens (IOL) power calculation accuracy. It notes that achieving high accuracy typically requires years of experience and expertise. Mirricon claims to provide highly accurate and consistent IOL power calculation with minimal training by using its proprietary technology. The document seeks partnership and investment opportunities to commercialize Mirricon, which has undergone physical optical testing in model eyes and an initial clinical study in 100 cataract patients.